Asciminib monotherapy in Ph+ CML: major molecular responses Presented ByProf. Timothy Hughes, University of Adelaide, Australia TrialPhase 1 ConferenceEHA 2020 9 September, 2020 13:08
20-Year follow-up of imatinib in chronic myeloid leukaemia after failure with interferon Presented ByDr Maria Vazquez, MD Anderson Cancer Center, Houston, USA ConferenceASH 2019 5 March, 2020 16:26